
3083. myocardial toxicity contrast agents used angiography 
myocardial toxicity many current 
experimental contrast agents 
studied dogs, use previously 
unreported method occlusion 
retrograde coronary venography well 
familiar technique selective 
coronary arterial catheterization.  following 
conclusions appear justified 
light experiments   
iodine-containing radicals 
contrast agents often identified (acetrizoates, 
diatrizoates, iothalamates, 
etc.), also final salification products appear 
responsible widely 
divergent degrees myocardial toxicity contrast 
agents, point differ- 
ent salts compound behave entirely 
different agents chemically 
biologically.  results seem indicate 
dominance sodium ion and/or 
protective effect methylglucamine salts 
respect myocardial toxi- 
city current radiopaque media.  reported, 
yet unexplained, electrocardiographic 
changes occurring within one two seconds 
beginning massive caval 
high-pressure injections appear find 
causal relationship myocardial ir- 
ritability induced distention 
coronary veins myocardial infiltra- 
tion intentionally enhanced 
retrograde injection techniques.  pe- 
culiar trait, shared varying degrees 
radiopaque agents tested, 
ability increase coronary blood flow. 
clinical significance phenome- 
non, however, remains established. 
studies re-emphasize limita- 
tions standard toxicity studies conducted 
animals.  clear 
results reported agents 
administered coronary circulation 
demand investigation regard 
potential toxicity methods described 
herein variations thereof.  fact, 
similar tests carried or- 
gans subjected radiographic 
examination via vascular bed.  authors 
hope presentation will stimulate 
renewed investigation, particularly view 
growing clinical applications 
selective cardiovascular opacification tech- 
niques. 
